77 related articles for article (PubMed ID: 7877583)
41. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
Bahrami S; Paul E; Redl H; Schlag G
Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
[No Abstract] [Full Text] [Related]
42. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801
[TBL] [Abstract][Full Text] [Related]
43. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
44. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
45. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats.
Inoue Y; Kohno S; Miyazaki T; Yamaguchi K
Tohoku J Exp Med; 1991 Mar; 163(3):175-85. PubMed ID: 2063402
[TBL] [Abstract][Full Text] [Related]
46. [Experimental ARDS and its prevention].
Matsuda M; Takahashi M
Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):869-72. PubMed ID: 6676658
[TBL] [Abstract][Full Text] [Related]
47. Pathogenesis of disseminated intravascular coagulation in sepsis.
Levi M; ten Cate H; van der Poll T; van Deventer SJ
JAMA; 1993 Aug; 270(8):975-9. PubMed ID: 8345649
[TBL] [Abstract][Full Text] [Related]
48. Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats.
Morooka S; Natsume Y
Adv Exp Med Biol; 1996; 416():189-93. PubMed ID: 9131147
[TBL] [Abstract][Full Text] [Related]
49. [Clinico-experimental analysis of backgrounds of the severe surgical infections].
Ono S; Tamakuma S; Mochizuki H; Kadota T; Yamamoto T
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1300-3. PubMed ID: 1944210
[TBL] [Abstract][Full Text] [Related]
50. Change in the acid protease activity in plasma of patients with disseminated intravascular coagulation.
Uetsuji S; Yamamura M; Tanaka T; Yamamoto M
Jpn J Surg; 1991 Sep; 21(5):517-20. PubMed ID: 1813688
[TBL] [Abstract][Full Text] [Related]
51. Pathogenesis and clinical features of acute cholangitis accompanied by shock.
Shimada H; Nakagawara G; Kobayashi M; Tsuchiya S; Kudo T; Morita S
Jpn J Surg; 1984 Jul; 14(4):269-77. PubMed ID: 6436560
[TBL] [Abstract][Full Text] [Related]
52. Intravascular release of platelet activating factor in children with sepsis.
Bussolino F; Porcellini MG; Varese L; Bosia A
Thromb Res; 1987 Dec; 48(5):619-20. PubMed ID: 3441909
[No Abstract] [Full Text] [Related]
53. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
Ono S; Tamakuma S; Mochizuki H; Kinoshita M; Ohkusa Y; Aosasa S; Oda Y; Ohe H
Surg Today; 1993; 23(3):228-33. PubMed ID: 8467174
[TBL] [Abstract][Full Text] [Related]
54. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
Paloma MJ; Páramo JA; Rifón J; Rocha E
Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
[TBL] [Abstract][Full Text] [Related]
55. Fibrinolysis in disseminated intravascular coagulation.
Hack CE
Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
[TBL] [Abstract][Full Text] [Related]
56. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Vervloet MG; Thijs LG; Hack CE
Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and experimental studies of septic DIC in surgical patients, in terms of its characteristic features and pathogenesis].
Ono S
Nihon Geka Gakkai Zasshi; 1994 Dec; 95(12):849-59. PubMed ID: 7877583
[TBL] [Abstract][Full Text] [Related]
58. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
Ono S; Mochizuki H; Tamakuma S
Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
